Synthetic Biology Market Set to Reach USD 66 Billion by 2030

Synthetic Biology Market Set to Reach USD 66 Billion by 2030

According to Next Move Strategy Consulting, the global Synthetic Biology Market, is projected to reach USD 66 billion by 2030, growing at an impressive compound annual growth rate (CAGR) of 23% from 2024 to 2030. Synthetic biology, the design and construction of new biological systems and the modification of existing ones for various applications, is transforming industries ranging from healthcare and agriculture to chemicals, energy, and environmental management.

Download Free Sample: https://www.nextmsc.com/synthetic-biology-market/request-sample

Key Drivers of Market Growth

The market's growth is largely driven by the increasing adoption of synthetic biology in healthcare. Gene therapies and precision medicine, particularly in the treatment of complex diseases like cancer and cardiovascular diseases, are revolutionizing patient care. For instance, collaborations like the one between the University of Texas MD Anderson Cancer Center and Rice University, which focuses on advancing cancer treatments through genome engineering, reflect the growing investment in synthetic biology applications. Additionally, in September 2023, Osaka University introduced a groundbreaking gene-editing technique, NICER, aimed at overcoming the limitations of existing CRISPR technology, further fueling market expansion.

Synthetic biology is also making significant strides in industrial biotechnology. In May 2024, Fermbox Bio launched a product pipeline using cellulosic enzyme cocktails to convert agricultural waste into ethanol, demonstrating the potential for biofuels to replace fossil fuels. The food and beverage sector is also witnessing innovation, with companies like Novozymes developing yeast technologies to improve ethanol production efficiency in corn plants, contributing to the growing demand for sustainable solutions.

Technological Advancements Driving Innovation

Key technological advancements such as CRISPR-Cas9 gene editing, synthetic DNA, and genome engineering are accelerating synthetic biology’s adoption. For example, Ginkgo Bioworks' acquisition of Reverie Labs in February 2024 exemplifies the increasing use of artificial intelligence (AI) to streamline genetic engineering processes. AI tools are enabling researchers to predict organism behavior with greater accuracy and speed, creating new possibilities for biotechnology and driving market growth.

Additionally, synthetic biology is expanding its footprint in agriculture with genetically modified crops designed to increase yields and enhance nutritional profiles, further solidifying the sector's importance.

Regional Insights

North America dominates the synthetic biology market due to the strong presence of biotechnology giants such as Ginkgo Bioworks, Thermo Fisher Scientific Inc., and Agilent Technologies. The U.S. biotech sector alone generated nearly USD 3 trillion in 2021, spurring significant investment in synthetic biology applications across healthcare, agriculture, and sustainability. Moreover, the U.S. government's initiatives to support biotechnology innovation are further accelerating market growth.

Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, driven by significant healthcare investments in countries like China and India. The region’s governments are also implementing policies to support synthetic biology R&D, fostering innovation in biomanufacturing and healthcare. South Korea’s launch of the National Synthetic Biology Initiative in 2023 is one example of these initiatives.

Inquire Before Buying: https://www.nextmsc.com/synthetic-biology-market/inquire-before-buying

Competitive Landscape

Leading players in the synthetic biology market include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Novozymes A/S, and Ginkgo Bioworks, among others. These companies are adopting various strategies, including mergers and acquisitions, to enhance their technological capabilities and market share. For instance, in October 2023, Thermo Fisher Scientific acquired Olink to advance its protein biomarker discovery and improve its life sciences research capabilities.

Conclusion

The synthetic biology market is poised for rapid growth, driven by technological advancements and expanding applications across diverse industries. With increasing investments in R&D, the integration of AI in genetic engineering, and the growing demand for sustainable solutions, synthetic biology is on track to play a pivotal role in solving some of the world’s most pressing challenges. As the market evolves, opportunities for innovation and investment will continue to thrive, unlocking new potentials for healthcare, agriculture, and industrial biotechnology.

Also, Browse Related Reports:   

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting: 

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Back to blog